Puma Biotechnology, Inc.
- Last sale
- Nov 12, 2026 · -0.06%
- Market cap
- $417.98M
- 51.7M shares
- Filings
- 1,023
Q3 2026−0.9% FY25 yoy
Q3 2026+2.8% FY25 yoy
Q3 2026+20.5% FY25 yoy
Q3 2026derived+7.4% FY25 yoy
Q3 2026−1.6% FY25 yoy
Q3 2026−57.2% FY25 yoy
- $417.98M
- 17.5×
- 1.8×
- 2.9×
- 11.02%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $228,371,000 | reported | |
| FY 2024 | 2024-12-31 | $230,468,000 | reported | |
| FY 2023 | 2023-12-31 | $235,637,000 | reported | |
| FY 2022 | 2022-12-31 | $228,031,000 | reported | |
| FY 2021 | 2021-12-31 | $253,155,000 | reported | |
| FY 2020 | 2020-12-31 | $225,110,000 | reported | |
| FY 2019 | 2019-12-31 | $272,260,000 | reported | |
| FY 2018 | 2018-12-31 | $250,991,000 | reported | |
| FY 2017 | 2017-12-31 | $27,685,000 | reported |
Segments
Products
LineFY2025ShareChange
Product$204.07M89%+4.6%
Royalty$24.30M11%−31.1%
License———
Total$228.37M
Pharmaceutical preparations
Puma Biotechnology, Inc. is the 81st largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
SDGRSchrodinger, Inc.$255.9M23.3%40.4%$2.3BRCUSArcus Biosciences, Inc.$247.0M4.3%142.9%$2.6BKROSKeros Therapeutics, Inc.$244.1M6,775.0%35.7%$197.2MAKBAAkebia Therapeutics, Inc.$236.2M47.5%2.3%$138.5MANABAnaptysbio, Inc$234.6M157.0%5.6%$1.4B
PBYIPuma Biotechnology, Inc. (this company)$228.4M0.9%13.6%$418.0M
IDYAIDEAYA Biosciences, Inc.$218.7M3,024.4%52.0%$3.0BVNDAVanda Pharmaceuticals Inc.$216.1M8.7%102.0%$238.9MAMRNAmarin Corp Plcuk$213.6M6.5%18.2%$4.9BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Puma Biotechnology, Inc. · CIK 1401667 · Engraved from SEC EDGAR